TABLE 1

Patients'characteristics during the study period

2005–20062007–20082009–20102011–2012p-value
Demographics
 Patients n6305809198119799
 Women1520 (24.1)2076 (25.7)2688 (27.4)2960 (30.2)<10−4
 Age ≥75 years853 (13.5)1159 (14.3)1463 (14.9)1568 (16)<10−4
Comorbidities per patient n
 0718 (11.4)874 (10.8)1038 (10.6)908 (9.2)<10−4
 11387 (22)1663 (20.5)1869 (19)1886 (19.2)
 21598 (25.3)1957 (24.2)2381 (24.3)2459 (25.1)
 32052 (32.5)2709 (33.5)3481 (35.5)3625 (37)
 4550 (8.7)888 (11)1042 (10.6)931 (9.4)
Surgical management<10−4
 Wedge673 (10.7)870 (10.7)963 (9.9)973 (9.9)
 Segmentectomy163 (2.6)235 (2.9)429 (4.4)535 (5.4)
 Lobectomy4169 (66.1)5390 (66.6)6688 (68.2)6805 (69.4)
 Bi-lobectomy309 (4.9)395 (4.9)471 (4.8)460 (4.7)
 Pneumonectomy991 (15.7)1201 (14.8)1260 (12.8)1026 (10.5)
 Systematic nodal dissection5014 (79.5)6724 (83.1)8441 (86)8489 (86.6)<10−4
 VATS lobectomy53 (1.2)82 (1.5)239 (3.5)730 (10.7)<10−4
 Extended resection499(8)627(7.8)739(7.5)713(7.3)0.45
 Bronchoplasty173(2.7)168(2)237(2.4)206(2)0.02
Perioperative management
 Neoadjuvant
  Chemotherapy968 (15.3)880 (10.9)1009 (10.3)843 (8.6)<10−4
  Radiotherapy149 (2.3)118 (1.4)133 (1.3)109 (1.1)<10−4
 Adjuvant
  Chemotherapy1296 (20.5)1485 (18.3)1421 (14.5)1501 (15.3)<10−4
  Radiotherapy509 (8.1)528 (6.5)434 (4.4)413 (4.2)<10−4
Histological type
 Squamous cells1894 (30)2249 (27.8)2691 (27.4)2531 (25.8)<10−4
 Adenocarcinoma2778 (44)3801 (47)4977 (50.7)5133 (52.4)
 Carcinoid193 (3)314 (3.9)377 (3.8)427 (4.3)
 Other383 (6)542 (6.7)558 (5.7)411 (4.2)
 Small cell lung cancer70 (1.1)78 (0.9)107 (1.1)81 (0.8)
Tumour classification
 IA1094 (17)1669 (21)2285 (23)2513 (26)<10−4
 IB1358 (21.5)1745 (21.5)2015 (20.5)1954 (20)
 IIA or B909 (14)1124 (14)1468 (15)1532 (16)
 IIIA943 (15)1192 (15)1481 (15)1382 (14)
 IIIB409 (6.5)515 (6)562 (6)427 (4)
 IV339 (5)449 (5.5)475 (5)377 (4)
  • Data are presented as n (%), unless otherwise stated. VATS: video assisted thoracic surgery.